EMERYVILLE, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing a large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides ® , today announced that Tom Paulson, Chief Financial Officer, will present at the 25th Annual ROTH Conference, held March 17-20, 2013, in Dana Point, California. Mr. Paulson will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
|Date||Tuesday, March 19, 2013|
|Time||5:00 pm PDT|
|Place||Ritz-Carlton, Laguna Niguel, Dana Point, CA|